|
FY2022
12 months to Jul 31, 2022
|
FY2021
12 months to Jul 31, 2021
|
FY2020
12 months to Jul 31, 2020
|
|
|---|---|---|---|
| Revenue from sale of goods | |||
| Excise taxes | |||
| Net revenue from sale of goods | |||
| Ancillary revenue | |||
| Net revenue | |||
| Cost of goods sold | |||
| Gross profit/(loss) before fair value adjustments | |||
| Fair value component in inventory sold | |||
| Unrealized gain on changes in fair value of biological assets | |||
| Gross profit/(loss) | |||
| Operating expenses | |||
| General and administrative | |||
| Selling, marketing and promotion | |||
| Share-based compensation | |||
| Research and development | |||
| Depreciation of property, plant and equipment | |||
| Amortization of intangible assets | |||
| Restructuring costs | |||
| Impairment of property, plant and equipment | |||
| Impairment of intangible assets | |||
| Impairment of goodwill | |||
| Recognition of onerous contract | |||
| Loss on disposal of property, plant and equipment | |||
| Impairment of investment in associate | |||
| Disposal of long-lived assets | |||
| (Gain) Loss on disposal of property, plant and equipment | |||
| Acquisition, integration and transaction costs | |||
| Total expenses, by nature | |||
| Loss from operations | |||
| Revaluation of financial instruments gain/(loss) | |||
| Share of loss from investment in associate and joint ventures | |||
| Loss on induced conversion of debentures | |||
| (Realized loss)/unrealized gain on convertible debenture receivable | |||
| Unrealized loss on investments | |||
| Realized gain on investments | |||
| Foreign exchange gain/(loss) | |||
| Interest and financing expenses | |||
| Interest income | |||
| Other income | |||
| Interest income (expense), net | |||
| Non-operating income (expense), net | |||
| Net loss before tax | |||
| Current and deferred tax recovery | |||
| Net loss and comprehensive loss | |||
| Net loss | |||
| Other comprehensive income | |||
| Foreign currency translation | |||
| Gain on fair value due to changes in credit spread, net of tax | |||
| Net loss and comprehensive loss | |||
| Net loss and comprehensive loss per share, basic and diluted (in dollars per share) | |||
| Net loss and comprehensive loss per share, basic | |||
| Net loss and comprehensive loss per share, diluted | |||
| Weighted average number of outstanding shares | |||
| Basic and diluted | |||
| Comprehensive loss attributable to: | |||
| Shareholders of HEXO Corp. | |||
| Non-controlling interest |
Loading...
